Back to Search
Start Over
National Institute of Allergy and Infectious Diseases (NIAID) Researchers Further Understanding of RNA Vaccines (A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever).
- Source :
- Vaccine Weekly; 6/15/2024, p813-813, 1p
- Publication Year :
- 2024
-
Abstract
- Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have made progress in understanding RNA vaccines for Crimean-Congo hemorrhagic fever (CCHF). CCHF is a tick-borne illness with a wide geographic distribution, and currently, there are no widely available vaccines for it. The researchers used a rhesus macaque model to evaluate the immunogenicity and protective efficacy of a replicating RNA vaccine. The results showed that the vaccine induced a robust immune response and provided significant protection against CCHF in non-human primates. This research contributes to the development of potential vaccines for CCHF. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 10742921
- Database :
- Supplemental Index
- Journal :
- Vaccine Weekly
- Publication Type :
- Periodical
- Accession number :
- 177701264